Skip to main content
Caplight Logo









Otologic Pharmaceutics

Otologic Pharmaceutics

Private
Oklahoma City, OklahomaHealthcare & Life Scienceshttps://otologicpharma.com

Last Round

Grant

Jul 30, 2020

Total Funding Raised

$11.7M

Company Overview

Otologic Pharmaceutics is a biopharmaceutical company that develops treatments for acute and chronic hearing loss.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

hearing loss therapeuticshearing loss drugclinical-stage biopharmanoise-induced hearing lossNIHLhair cell regenerationhearing restorationsiRNA therapyregenerative medicinetinnitus treatmentage-related hearing lossotologydrug licensinghearing preservationDoD medical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Otologic Pharmaceutics Comparables

Compare Otologic Pharmaceutics with similar companies based on industry and business-model similarity.

Otologic Pharmaceutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Gateway Biotechnology, Inc.
88%
Sound Pharmaceuticals, Inc.
85%
AudioCure Pharma
84%

Otologic Pharmaceutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 30, 2020
GrantOct 1, 2017
GrantNov 19, 2014
Series AApr 3, 2014

Key People

Founding team and executive leadership

Gareth Willis

Chief Operating Officer

Executive Team

Otologic Pharmaceutics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 30, 2020

    $300K grant from Oklahoma Center for the Advancement of Science and Technology

Otologic Pharmaceutics Filings

Explore SEC and related filing metadata, where available.

Otologic Pharmaceutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Otologic Pharmaceutics's valuation, stock price, and market status.

Is Otologic Pharmaceutics a public or private company?

Otologic Pharmaceutics is a private company.

What is the current stock price of Otologic Pharmaceutics?

Otologic Pharmaceutics is a private company with no public stock price. No recent secondary market data is available.

How much is Otologic Pharmaceutics worth (valuation)?

Valuation information for Otologic Pharmaceutics is not publicly available.

Can I buy Otologic Pharmaceutics stock?

Otologic Pharmaceutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Otologic Pharmaceutics's last funding round?

Funding round information for Otologic Pharmaceutics is not publicly available.

Who are the main investors in Otologic Pharmaceutics?

Investor information for Otologic Pharmaceutics is not publicly disclosed.

Will Otologic Pharmaceutics IPO soon?

No public IPO plans have been announced for Otologic Pharmaceutics.

How can I track Otologic Pharmaceutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Otologic Pharmaceutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOklahoma City, Oklahoma
Employee Range2
Year Founded2009
Last FundingJul 30, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?